Aethlon Medical (NASDAQ:AEMD – Get Free Report) and Co-Diagnostics (NASDAQ:CODX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.
Valuation & Earnings
This table compares Aethlon Medical and Co-Diagnostics”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aethlon Medical | $570,000.00 | 14.83 | -$12.21 million | ($2.82) | -0.21 |
| Co-Diagnostics | $7.32 million | 3.18 | -$35.33 million | ($1.38) | -0.53 |
Aethlon Medical has higher earnings, but lower revenue than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aethlon Medical | 0 | 0 | 1 | 0 | 3.00 |
| Co-Diagnostics | 0 | 1 | 0 | 0 | 2.00 |
Aethlon Medical currently has a consensus target price of $7.00, indicating a potential upside of 1,055.88%. Co-Diagnostics has a consensus target price of $1.50, indicating a potential upside of 105.48%. Given Aethlon Medical’s stronger consensus rating and higher possible upside, equities analysts clearly believe Aethlon Medical is more favorable than Co-Diagnostics.
Institutional & Insider Ownership
2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are held by institutional investors. 1.1% of Aethlon Medical shares are held by company insiders. Comparatively, 6.1% of Co-Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Volatility and Risk
Aethlon Medical has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of -0.9, meaning that its share price is 190% less volatile than the S&P 500.
Profitability
This table compares Aethlon Medical and Co-Diagnostics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aethlon Medical | N/A | -160.36% | -115.74% |
| Co-Diagnostics | -563.93% | -54.94% | -49.28% |
Summary
Aethlon Medical beats Co-Diagnostics on 8 of the 14 factors compared between the two stocks.
About Aethlon Medical
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
About Co-Diagnostics
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
